全球药用管瓶市场：市场规模（按数量、分销类型、瓶盖尺寸和地区划分）、未来预测

药用管瓶的市场规模及预测

2024 年药用管瓶市场规模价值 148.2 亿美元，预计到 2032 年将达到 216.3 亿美元，2026 年至 2032 年的复合年增长率为 6.94%。

药用管瓶是用来储存和保护液体药物、疫苗和其他医疗产品的小型圆柱形容器。管瓶采用优质耐化学腐蚀玻璃製成，可确保内容物的稳定性和完整性。它们设计为使用橡胶塞或金属盖密封，以保持无菌并防止污染。

药用玻璃瓶用于安全、无菌地储存药品、疫苗和有机物质。它们能够有效阻隔感染、光线和湿气，确保内容物的稳定性和有效性。由于玻璃瓶能够保持精密连接的完整性，因此常用于注射剂、口服液和诊断剂。

随着药物传输和包装技术的进步，药用管瓶的应用预计将持续扩展。玻璃瓶将继续成为注射药物（包括生技药品和疫苗）安全储存和给药的关键。玻璃配方和管瓶设计的创新将提高耐用性和安全性，降低污染风险，并支持新型药物疗法的开发。

全球药用管瓶市场动态

影响全球药用管瓶市场的关键市场动态是：

关键市场驱动因素

生技药品和疫苗的成长：生技药品和疫苗的不断发展和商业化，极大地推动了对药用管瓶的需求。这些产品通常需要无菌且安全的包装，以保持其效力和稳定性。管瓶因其能够提供惰性保护性环境，防止化学反应和污染而受到青睐。

慢性病发生率上升：全球范围内，糖尿病、癌症和心血管疾病等慢性病的发生率上升，推动了对注射药物和生技药品的需求。这些治疗通常需要精确、无菌的包装解决方案，以确保安全性和有效性。管瓶是包装这些药物的必备材料，因为它们可以保持精细化合物的完整性。

管瓶的技术进步：管瓶製造技术的创新是市场的主要驱动因素。防篡改功能、防碎玻璃配方以及灭菌技术的改进等进步，使管瓶更加安全、耐用且功能更强大。

主要挑战

污染和破损风险：药用管瓶易受污染和破损，这可能会损害其所含药品的无菌性和安全性。玻璃颗粒可能会进入药物并引起副作用。确保管瓶无缺陷并在生产过程中进行严格的品管至关重要。此外，必须严格控制搬运和储存方法，以防止物理损坏。

製造和材料成本：生产药用管瓶成本高昂，因为需要高品质的玻璃材料和先进的製造技术，而且由于需要专门的设备来确保管瓶尺寸精确一致以及严格的灭菌程序，成本进一步增加。

法规合规性和标准：药用玻璃瓶必须遵守严格的法规要求和行业标准，以确保安全性、有效性和品质。遵守FDA和EMA等国际法规需要不断更新和修改，以跟上不断发展的标准。这要求製造商在法规业务方面投入资金，进行广泛的测试，并准备好文件以证明其合规性。

主要趋势：

玻璃配方和技术进步：全球药用玻璃瓶市场在玻璃製造和技术方面取得了长足的进展。新型GLA（例如I型硼硼硅酸玻璃）具有更高的耐热性和耐化学反应性，这对于易损药品和生物製药的保存至关重要。玻璃盖技术的创新提高了化学稳定性，降低了药物残留和相互作用的风险。

生技药品和个人化医疗的成长：生技药品和个人化医疗的兴起是影响药用玻璃瓶市场的一大趋势。疫苗、单株抗体和基因疗法等生技药品需要无菌、高品质的包装解决方案来维持其功效和安全性。管瓶因其惰性和良好的抗污染性能而成为这些应用的首选。

永续性与环保考量：在日益严格的环境法规和企业责任倡议的推动下，永续性已成为药用管瓶市场的关键趋势。该产业正在探索减少玻璃塑胶生产和处置对环境影响的方法，包括实施回收计画和采用环保的生产流程。

目录

第一章 引言

• 市场定义
• 细分市场
• 分析方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

4. 药用管瓶市场（按数量）

• 小容量管瓶（小于5毫升）
• 大容量管瓶（5毫升或以上）

5. 药用管瓶市场（依分销类型）

• 直销
• 经销商
• 网路市集

6. 药用管瓶市场（按瓶盖尺寸）

• 13毫米管瓶
• 20毫米管瓶
• 附加尺寸

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• 肖特股份公司（德国）
• 日本硝子株式会社（日本）
• Bharat Parenterals Limited（印度）
• Gerresheimer AG（德国）
• SGD Pharma（瑞士）
• 碧迪公司（BD）（美国）
• 肖特股份公司（德国）
• AptarGroup, Inc.（美国）
• Ompi有限公司（瑞士）
• 中性玻璃集团（中国）

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Pharmaceuticals Glass Vials Market Size and Forecast

Pharmaceuticals Glass Vials Market Size was valued at USD 14.82 Billion in 2024 and is projected to reach USD 21.63 Billion by 2032, growing at a CAGR of 6.94% from 2026 to 2032.

Pharmaceutical glass vials are small, typically cylindrical containers used to store and protect liquid medications, vaccines, and other pharmaceutical products. Made from high-quality, chemically resistant glass, these vials ensure the stability and integrity of the contents. They are designed to be sealed with rubber stoppers and metal caps to maintain sterility and prevent contamination.

Pharmaceutical glass bottles are used for the safe and sterile storage of medicines, vaccines, and organic substances. They offer a barrier against infection, light, and humidity, thus guaranteeing the stability and effectiveness of the content. Glass bottles are often used for injectable medicines, oral liquids, and diagnostic reagents and the ability to maintain the integrity of sensitive connections.

The future use of glass vials for pharmaceuticals is expected to grow with advances in drug delivery and packaging technologies. They will continue to be essential for the safe storage and administration of injectable drugs including biologics and vaccines. Innovations in glass formulations and vial design will improve durability and safety, reduce contamination risks, and support the development of new drug therapies.

Global Pharmaceuticals Glass Vials Market Dynamics

The key market dynamics that are shaping the global Pharmaceuticals Glass Vials Market include:

Key Market Drivers:

Growth in Biologics and Vaccines: The increasing development and commercialization of biologics and vaccines is significantly driving the demand for glass vials for pharmaceutical products. These products often require sterile and secure packaging to maintain their potency and stability. Glass vials are preferred for their ability to provide an inert and protective environment preventing chemical interactions and contamination.

Rising Incidences of Chronic Diseases: The global rise in chronic diseases such as diabetes, cancer, and cardiovascular diseases is driving the demand for injectable drugs and biologics. These treatments often require precise and sterile packaging solutions to ensure their safety and efficacy. Glass vials are essential for packaging these medications as they can preserve the integrity of the delicate compounds.

Advancements in Glass Vial Technology: Innovations in glass vial manufacturing technology are a key driver of the market. Advancements such as the development of tamper-evident features, shatter-resistant glass formulations, and improved sterilization techniques are improving the safety, durability, and functionality of glass vials.

Key Challenges:

Risk of Contamination and Breakage: Pharmaceutical glass vials are susceptible to contamination and breakage which can compromise the sterility and safety of the medications they contain. Glass particles can potentially mix with the drug leading to adverse reactions. Ensuring that vials are free from defects and maintaining strict quality control during production is crucial. Additionally, handling and storage practices must be meticulously managed to prevent physical damage.

Cost of Production and Material: Producing pharmaceutical glass vials requires high-quality glass materials and advanced manufacturing techniques which can be costly. Expenses are further compounded by the need for specialized equipment to ensure accurate and consistent vial dimensions as well as rigorous sterilization procedures.

Regulatory Compliance and Standards: Pharmaceutical glass vials must adhere to stringent regulatory requirements and industry standards to ensure safety, efficacy, and quality. Compliance with international regulations such as those set by the FDA and EMA involves continuous updates and modifications to meet evolving standards. This requires manufacturers to invest in regulatory affairs, conduct extensive testing, and maintain documentation to demonstrate compliance.

Key Trends:

Advancements in Glass Formulation and Technology: The global glass bottle market in pharmaceutical products has considerable progress in glass manufacturing and technology. The new types of GLA such as type I borosilicate glass offer improved resistance to heat and chemical reactions which is of crucial importance for the storage of sensitive drugs and biologicals. Innovations in glass-covering technologies improve chemical stability and reduce the risk of leaving or interacting with drugs.

Growth in Biologics and Personalized Medicine: The increasing prevalence of biologics and personalized medicine is a key trend influencing the Pharmaceuticals Glass Vials Market . Biologics including vaccines, monoclonal antibodies, and gene therapies require sterile and high-quality packaging solutions to maintain efficacy and safety. Glass vials are preferred for these applications due to their inert nature and ability to protect against contamination.

Sustainability and Environmental Concerns: Sustainability has become an important trend in the market for glass bottles in pharmaceuticals which is due to rising environmental regulations and initiatives for corporate responsibility. The industry examines paths to reduce the environmental impact of glass plastic production and disposal, e.g. the implementation of recycling programs and the use of environmentally friendly manufacturing processes.

Global Pharmaceuticals Glass Vials Market Regional Analysis

Here is a more detailed regional analysis of the global Pharmaceuticals Glass Vials Market :

North America:

North America is the most dominant region in the pharmaceutical glass vials market. This dominance is primarily due to the presence of a well-established pharmaceutical industry and significant investments in research and development. The United States and Canada are home to numerous major pharmaceutical companies and contract manufacturing organizations that require high-quality glass vials for their pharmaceutical products including biologics and vaccines.

Additionally, North America's focus on innovation and growth in personalized medicine and biologics has intensified the need for specialized glass vials that can meet the unique requirements of these complex pharmaceutical formulations. The region's strong infrastructure including state-of-the-art manufacturing facilities and robust distribution networks supports its leading position in the global market.

Asia Pacific:

Asia Pacific is the fastest-growing region in the global pharmaceutical glass vials market. This growth is driven by rapid industrialization, increasing investments in healthcare infrastructure, and rising demand for pharmaceuticals and biologics. Countries such as China and India are expanding their pharmaceutical manufacturing capacity and increasing their production of injectable drugs, thereby significantly increasing the demand for glass vials.

Additionally, increasing local production of vaccines and biologics owing to global healthcare initiatives is further increasing the need for high-quality glass vials. In addition, the Asian-Pacific space benefits from cheap production and favorable regulatory environments and attracts local and international pharmaceutical companies. The accent put by the region on the improvement of health standards and the expansion of the pharmaceutical sector creates a robust market for glass bottles.

Pharmaceuticals Glass Vials Market: Segmentation Analysis

The Global pharmaceutical glass vials market is segmented based on Capacity, Mode of Distribution, Cap Size, and Geography.

Pharmaceuticals Glass Vials Market, By Capacity

• Small Volume Vials (less than 5ml)
• Big Volume Vials (5 ml or more)

Based on the Capacity, the Global Pharmaceuticals Glass Vials Market are bifurcated into Small Volume Vials, and Big Volume Vials. In the global Pharmaceuticals Glass Vials Market , small-volume vials are more dominant in the Pharmaceuticals Glass Vials Market . This dominance is driven by their widespread use in storing and administering high-value, potent medications, such as vaccines and biologics which often require precise, small doses. Their compact size makes them ideal for single-use or multi-dose applications ensuring accurate dosage and minimizing waste.

Pharmaceuticals Glass Vials Market, By Mode of Distribution

• Direct Sales,
• Distributors,
• Online Marketplaces

Based on the Mode of Distribution, the global Pharmaceuticals Glass Vials Market is bifurcated into Direct Sales, Distributors, and Online Marketplaces. In the global pharmaceutical glass vials market, direct sales are more dominant in the pharmaceutical glass vials market due to the need for specialized, high-quality packaging solutions that require close interaction between manufacturers and pharmaceutical companies. Direct sales enable manufacturers to provide tailored solutions offer technical support, and ensure compliance with stringent regulatory standards.

Pharmaceuticals Glass Vials Market, By Cap Size

13mm Vials,

20 mm Vials,

• Additional Sizes

Based on the Cap-Size Type, the Global Pharmaceuticals Glass Vials Market is bifurcated into 13mm Vials, 20 mm Vials, and Additional Sizes. In the global Pharmaceuticals Glass Vials Market , 20 mm vials are more dominant in the Pharmaceuticals Glass Vials Market due to their versatility and suitability for a wide range of drug applications including larger volume injectables and biologics. Their larger capacity accommodates more complex and high-volume formulations, which are increasingly common in the pharmaceutical industry.

Pharmaceuticals Glass Vials Market, By Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Rest of the world

Based on Geography, the Global Pharmaceuticals Glass Vials Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and the Rest of the world. North America is the most dominant region in the Pharmaceuticals Glass Vials Market due to its advanced pharmaceutical industry, significant investments in research and development, and high demand for high-quality packaging solutions. The region's well-established infrastructure and stringent regulatory standards drive the need for superior glass vials to ensure drug safety and efficacy.

Key Players

The "Global Pharmaceuticals Glass Vials Market " study report will provide valuable insight with an emphasis on the global market. The major players in the market are Schott AG, Nippon Glass Ltd., Bharat Parenterals Limited, Gerresheimer AG, SGD Pharma, Becton, Dickinson and Company, SCHOTT AG, AptarGroup, Inc., Ompi Ltd., and Neutral Glass Group.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Pharmaceuticals Glass Vials Market Key Developments

• In June 2023, SDG SA announced its partnership with Corning Incorporated to establish a glass tubing facility in Telangana, India. The partnership combined SDG's expertise with Corning's glass coating technology to enhance fine-line productivity, thus initiating expansion in pharmaceutical manufacturing.
• In May 2023, Bormioli Pharma S.p.A renewed its partnership with Desall.com to develop innovation and ideas about pharmaceutical packaging by focusing on augmented reality solutions for drug delivery, and biometric recognition solutions to transform child-resistant closure systems.
• In March 2023, Schott AG launched the production of FIOLAX(R)amber pharma glass in India to meet its increasing demand in Asia. This production will improve the reliability, planning, availability, and cost-efficiency of pharmaceutical converters.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Pharmaceuticals Glass Vials Market, By Capacity

• Small Volume Vials (less than 5ml)
• Big Volume Vials (5 ml or more)

5. Pharmaceuticals Glass Vials Market, By Mode of Distribution

• Direct Sales
• Distributors
• Online Marketplaces

6. Pharmaceuticals Glass Vials Market, By Cap Size

• 13mm Vials
• 20 mm Vials
• Additional Sizes

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Schott AG (Germany)
• Nippon Glass Ltd. (Japan)
• Bharat Parenterals Limited (India)
• Gerresheimer AG (Germany)
• SGD Pharma (Switzerland)
• Becton, Dickinson and Company (BD) (US)
• SCHOTT AG (Germany)
• AptarGroup, Inc. (US)
• Ompi Ltd. (Switzerland)
• Neutral Glass Group (China)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References